<DOC>
	<DOCNO>NCT03090776</DOCNO>
	<brief_summary>Aim 1 : To determine effectiveness perioperatively administer ketamine decrease acute persistent postmastectomy pain ( PPMP ) . Hypothesis 1.1 : Patients undergo partial total mastectomy treat bolus perioperative infusion NMDA-receptor antagonist ketamine decrease postoperative pain opioid utilization compare receive saline control . Hypothesis 1.2 : Patients undergo partial total mastectomy treat bolus perioperative infusion NMDA-receptor antagonist ketamine decrease persistent postoperative pain measure one year surgery . Aim 2 : To determine whether increased power detect therapeutic effectiveness interventional preventive trial , enrichment patient high risk PPMP . Hypothesis 2.1 : Ketamine great analgesic opioid spar effect pain score high-risk patient non-high risk patient , compare placebo . Hypothesis 2.2 : Ketamine great preventive effect pain burden score one year surgery high-risk patient non-high risk patient , compare placebo .</brief_summary>
	<brief_title>Prevention Post Mastectomy With Intraoperative Ketamine</brief_title>
	<detailed_description>V. STUDY PROCEDURES 1 . Preoperative evaluation 1 . Psychosocial Assessment : After patient give informed consent , preoperative demographic , medical , psychosocial pain questionnaire complete patient preoperative office visit . Questionnaires assess psychosocial factor choose base upon previous retrospective association PPMP , preliminary evidence prospective study population , strong psychometric validation characteristic , brevity . The Pain Catastrophizing Scale ( PCS ) , validate pain patient control , use measure catastrophic thinking associate pain . Depressive symptom , anxiety sleep disturbance assess use short-form instrument NIH roadmap initiative , Patient Reported Outcome Measurement Information System ( PROMIS ) . The PROMIS instrument extensively validated study compare result establish scale , calibrate 20,000 persons.The Brief Symptom Index 18-Somatization Scale , also previously validate chronic pain patient , use measure somatization . The Positive Affect/Negative Affect Scale ( PANAS ) measure affective stance . 2 . Pain assessment : The primary pain outcome measure Pain Burden Index measure Breast Cancer Pain Questionnaire ( BCPQ ) , originally develop Gartner et al use 600 patient previous study . The BCPQ include assessment average pain , pain frequency ( many days/week ) , specific assessment pain 4 body area ( breast , arm , side , axilla ) , Pain Burden Index ( PBI ) calculate . A late iteration BCPQ also include question body pain , seek medical help pain , painkiller use , neuropathic/sensory symptom , functional impairment due pain , successfully employ current prospective observational study . We also use Brief Pain Inventory , well-validated general measure pain disability bad pain , least pain , interference . We supplement standard VAS assess pain without arm movement deep inspiration . The Pain Coping Questionnaire administer prospectively assay effective coping strategy use patient use 2 item version questionnaire ass use strategy . 3 . Quantitative sensory testing : 1 . Pressure pain test method : Pressure pain threshold tolerance assess similar manner previous study use digital pressure algometer ( Wagner FDX , Greenwich , CT , USA ) flat round transducer , probe area 0.785 cm2 . Testing site bilateral dorsal aspect proximal forearm ( extremity site ) trapezius muscle upper back ( truncal site ) . For pressure threshold determination , pressure increase steady rate approximately 1 lb/second subject indicate pressure first perceive painful . Pressure Pain Tolerance determine instruct patient indicate pressure pain longer tolerable . Two trial perform site . 2 . Temporal Summation test method : Mechanical pinprick pain assess similar manner previous study use standardize weighted pinprick applicator similar describe Rolke et al use range force ( 128 mN , 256mN 512mN ) result painful sensation subject . First , single stimulation lower force pinprick apply dorsal aspect index finger first second interphalangeal joint hand rest palm armrest , rat subject scale 0-10 . Next , break least 10 second , train 10 stimulus apply premarked spot , rate 1 stimulation/second . The subject rate pain scale 0-10 first , fifth tenth stimulus , rate ongoing pain 15 second cessation last stimulus . The procedure repeat third finger hand . Subjects undergo two trial force , break least one minute trial . 4 . Genetic sample collection : In order obtain genetic information particular genetic site variability may impact post-surgical pain , collect saliva sample use Oragene Self-Collection kit . This procedure non-invasive , safe , effective , widely use . Samples label alphanumeric code NOT include subject 's name , initial , medical record number , date birth , Social Security number order protect subject 's privacy confidentiality . The code key keep seperate secure location . Any tissue samples/data send outside Partners label name , birth date , medical record social security number . 2 . Perioperative intervention Patients receive 0.5 mg/kg dose IV ketamine ( max dose 50 mg ) volume saline 15 minute induction general anesthesia . Thereafter , continuous infusion 0.15 mg/kg/hr ketamine maximum dose 15 mg/hr saline administer end surgery ( surgical closure begin , approximately 30-60 minute prior emergence general anesthesia ) . The investigational drug service prepare blind solution ( 2 mg/mL ketamine saline ) deliver OR pharmacy begin case hands-on provider . Cost ketamine $ 12 per 200 mg vial , cover NIH K23 budget . General anesthesia provide hands-on anesthetist , free use discretion follow anesthetic drug , typically used population , compatible solution ketamine : Midazolam 2 mg , Fentanyl &lt; 500 mcg , Dilaudid &lt; 5 mg total , Propofol 1-2 mg/kg , Lidocaine 50-100 mg , Vecuronium , Rocuronium , succinylcholine Cisatracurium need , Zofran 4 mg , Decadron 4 mg , Cefazolin , Glycopyrrolate Neostigmine need reversal , well inhalational agent nitrous oxide . Subject investigator blind screen treatment : As part inform consent , subject appraise fact study investigate risk short- long-term pain whether people different risk group respond treatment , tell whether consider high- low- risk , whether receive ketamine placebo . Effectiveness blind assessed query patient group think POD1 . Investigator hands-on provider blind treatment ( ketamine v placebo ) . Nursing staff PACU appraise fact patient study , also blind treatment . Effectiveness blind study staff ask patient rate perioperative pain achieve study staff record impression group single item questionnaire Redcap system . Responses patient study staff impression group compare actual group end study . 3 . Perioperative data collection 1 . Surgical , Anesthetic , analgesic data collection : Using Weiner preoperative evaluation center email alert system , hands-on anesthetist and/or anesthesiologist contact inform patient 's participation study , give instruction volume bolus rate infusion . The total time volume infusion record record anesthetic record , total dose ketamine calculate . In order adjust potential impact anesthetic technique pharmacological agent PPMP , follow data extract electronic anesthesia record : Primary anesthetic method ( volatile vs. IV propanol vs. regional/paravertebral vs. combine PVB/GA ) , amount type local anesthetic administer , opioid analgesic use ( latter express morphine equivalent units/hr ) . In addition , information relevant analgesic preoperative , intraoperative , postoperative medication Oxycontin , gabapentin , pregabalin , dexmedetomidine gather electronic record . Other potentially confound intraoperative factor vasopressor use/amount , fluid blood administer , total anesthesia time , airway management ( LMA , ETT , native ) record . Among group breast surgeon , relative homogeneity anatomical technique tissue disturbance , although variation dissection technique . Detailed assessment surgical technique include primary surgeon , duration surgery , presence bilateral surgery , type surgery ( total mastectomy , segmental mastectomy ) , performance nodal dissection ( axillary sentinel node ) , presence type concurrent reconstruction . 2 . Acute postoperative pain assessment : Initial pain score upon arrival assess PACU nurse staff and/or anesthetist . One hour 24 hour PACU arrival , patient assess research study personnel , ask rate pain rest , arm movement , maximal deep inspiration use pain verbal rating scale ( VRS ) . Presence nausea treatment supplemental antiemetic recovery area record . In addition , opioid consumption adjuvant analgesic use ascertain patient 's medication administration record . Upon discharge , typically POD1 2 mastectomy patient , total postoperative opioid use/hours postoperative time inpatient calculate expressed morphine equivalent units/hr . On postoperative day 1 , mastectomy patient undergo brief bedside QST ( preoperative evaluation , describe ) . 3 . Persistent pain , long term psychosocial psychophysical assessment : Follow assessment persistent pain use BCPQ , BPI , VAS , pain coping questionnaire make 2 week , 3 mo , 6 mo , 12 , 24 mo , follow-up either via secure link REDcap electronic data capture system . Patients see visit surgical team , oncologists time . The brief QST psychosocial questionnaire re-administered 2 week 1 year postoperatively one patient 's follow-up visit .</detailed_description>
	<mesh_term>Chronic Pain</mesh_term>
	<mesh_term>Pain , Postoperative</mesh_term>
	<mesh_term>Ketamine</mesh_term>
	<criteria>Inclusion criterion : female aged 1885 year schedule total partial mastectomy willingness undergo psychophysical psychosocial test willingness participate longterm followup willingness randomize treatment IV ketamine saline general anesthesia . Exclusion criterion : schedule biopsy pregnant elevate ICP schizophrenia bipolar disorder allergy ketamine Class III high heart failure</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>85 Years</maximum_age>
	<verification_date>March 2017</verification_date>
</DOC>